Vimarsana
Biggest News Aggregation in the World

Love Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Love Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Love Pharma Today - Breaking & Trending Today

New Investing Ideas (OTCQX: IESVF) (TSXV: RGX) (CSE: JOLT) (NYSE American: SGE) (Nasdaq: CWD) - Vimarsana News

New Investing Ideas (OTCQX: IESVF) (TSXV: RGX) (CSE: JOLT) (NYSE American: SGE) (Nasdaq: CWD)

New Investing Ideas (OTCQX: IESVF) (TSXV: RGX) (CSE: JOLT) (NYSE American: SGE) (Nasdaq: CWD)

Jolt Health Inc taps early investor Gerald Tritt as CEO to lead biotechnology, healthcare and AI initiatives - Vimarsana News

Jolt Health Inc taps early investor Gerald Tritt as CEO to lead biotechnology, healthcare and AI initiatives

Jolt Health Inc, formerly known as Love Pharma, revealed that early-stage investor and seasoned entrepreneur Gerald Tritt is the company’s new chief...

LOVE Pharma Inc. Announces Change Of Name To Jolt Health Inc. And Increased Focus On Biotechnology - Vimarsana News

LOVE Pharma Inc. Announces Change Of Name To Jolt Health Inc. And Increased Focus On Biotechnology

VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has changed its name to "Jolt Health Inc.".

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO "JOLT HEALTH INC." AND INCREASED FOCUS ON BIOTECHNOLOGY Seite 1 - Vimarsana News

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO "JOLT HEALTH INC." AND INCREASED FOCUS ON BIOTECHNOLOGY Seite 1

17.05.2023 - VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) - LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0)  is pleased to announce that it has changed its name to “Jolt Health Inc.”.  The board of directors of the Company approved ... Seite 1

Love Pharma Inc. Announces Share Consolidation - Vimarsana News

Love Pharma Inc. Announces Share Consolidation

VANCOUVER, BC / ACCESSWIRE / February 27, 2023 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0) announced it intends to proceed with a consolidation of its common shares (each, a "Share")